Results 51 to 60 of about 403,789 (225)

The incidence of vaccine‐associated sarcomas in cats: a systematic review and meta‐analysis

Journal of Small Animal Practice, EarlyView.
Objectives Feline injection‐site sarcoma is a rare but serious adverse event associated with vaccination in cats. Published estimates of feline injection‐site sarcoma incidence vary widely, contributing to uncertainty in clinical decision‐making and incidence communication.
F. Emdin, S. G. Naro, P. M. Hoang, K. A. Brown, N. Daneman, J. S. Weese   +5 more
wiley   +1 more source

A time-resolved fluoroimmunoassay to assay the rabies virus glycoprotein: application for estimation of human rabies vaccine potency

Scientific Reports, 2017
Replacement of the in vivo rabies vaccine potency test (NIH test) by in vitro methods had been discussed by several researcher including WHO expert working groups.
Guanfeng Lin, Shaolang Chen, Hui Zhao, Junyu Liang, Qiaoting Deng, Rongliang Liang, Xinxin Guo, Zhenhua Chen, Baihong Chen, Tiancai Liu, Yingsong Wu   +10 more
doaj   +1 more source

Treatment of Canine Atopic Dermatitis: Updated Guidelines From the International Committee on Allergic Diseases of Animals (ICADA)

Veterinary Dermatology, EarlyView.
ABSTRACT Background Canine atopic dermatitis (cAD) is a genetically, aetiologically, immunologically and clinically complex disease requiring both individualised immediate and long‐term management. Objectives These updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA) aim to substantially revise previous ...
Ralf S. Mueller, Frane Banovic, Emmanuel Bensignor, Domenico Santoro, Tim Nuttall   +4 more
wiley   +1 more source

Oral vaccination of wildlife using a vaccinia–rabies-glycoprotein recombinant virus vaccine (RABORAL V-RG®): a global review

Veterinary Research, 2017
RABORAL V-RG® is an oral rabies vaccine bait that contains an attenuated (“modified-live”) recombinant vaccinia virus vector vaccine expressing the rabies virus glycoprotein gene (V-RG).
Joanne Maki, Anne-Laure Guiot, Michel Aubert, Bernard Brochier, Florence Cliquet, Cathleen A. Hanlon, Roni King, Ernest H. Oertli, Charles E. Rupprecht, Caroline Schumacher, Dennis Slate, Boris Yakobson, Anne Wohlers, Emily W. Lankau   +13 more
doaj   +1 more source

A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C.

PLoS Neglected Tropical Diseases, 2020
Rabies, caused by RNA viruses in the Genus Lyssavirus, is the most fatal of all infectious diseases. This neglected zoonosis remains a major public health problem in developing countries, causing the death of an estimated 25,000-159,000 people each year,
Federico Napolitano, Rossella Merone, Adele Abbate, Virginia Ammendola, Emma Horncastle, Francesca Lanzaro, Marialuisa Esposito, Alessandra Maria Contino, Roberta Sbrocchi, Andrea Sommella, Joshua D Duncan, Jospeh Hinds, Richard A Urbanowicz, Armin Lahm, Stefano Colloca, Antonella Folgori, Jonathan K Ball, Alfredo Nicosia, Benjamin Wizel, Stefania Capone, Alessandra Vitelli   +20 more
doaj   +1 more source

Participatory Communication and Mass Dog Vaccination for Effective Rabies Management in Mitooma District, Western Uganda: An Exploratory Study

Public Health Challenges, Volume 5, Issue 4, December 2026.
This study evaluates participatory communication strategies in mass dog vaccination campaigns within Mitooma District. By actively engaging local communities, the initiative significantly enhanced vaccination coverage, improved public awareness of rabies prevention, and established a scalable, community‐driven framework for effective zoonotic disease ...
Augustino Ngabirano, Matthew Chibunna Igwe, Charles Idehen   +2 more
wiley   +1 more source

First Oral Rabies Vaccine for Dogs

, 2023
When it comes to free-roaming dogs, oral rabies vaccination (ORV) may play a crucial role in the global fight against canine rabies and could revolutionise the progress towards the ‘Zero by 30’ global strategic plan.
Müller, Thomas, WOAH Reference Centre for rabies, Freuling, Conrad Martin   +2 more
core  

A novel ELISA for quantification of glycoprotein in human rabies vaccines using a clinically proven virus neutralizing human monoclonal antibody

Human Vaccines & Immunotherapeutics, 2020
Global efforts on the replacement of the in vivo rabies vaccine potency test (NIH method) with in vitro methods for quantification of immunodominant glycoprotein (GP) in rabies vaccine have made significant progress.
Sunil Gairola, Manish Gautam, Satish Waghmare   +2 more
doaj   +1 more source

Biochemistry and Clinical Biochemistry Department, Faculty of Veterinary Medicine, Benha University [PDF]

Benha Veterinary Medical Journal, 2016
Aiming to raise the levels of immunity induced in dogs by the cell culture inactivated rabies vaccine, bee venom BV wassubjected to investigate its immune stimulant effect in vaccinated dogs.
Khodeir H., El-Nahas M., El-Bagoury F., Eiaka M.   +3 more
doaj   +1 more source

Travel vaccination for rabies

Expert Review of Vaccines, 2008
Rabies is a widely distributed zoonotic disease of major public-health importance. While canine rabies has been controlled throughout most of the developed world, it remains a significant burden in developing countries, particularly in Africa and Asia.
Jesse D, Blanton, Charles E, Rupprecht
openaire   +2 more sources